Palvella Therapeutics, Inc. Income Statement

Income Statement Dec2013 Jun2014 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 12.43M5.37M2.93M5.83M25.27M29.10M46.28M29.32M31.42M25.90M42.81M-0.43M
Operating items
Research & Development 9.41M5.60M8.24M19.70M22.29M41.49M55.00M46.53M66.66M52.98M8.79M8.15M
Selling, General & Administrative 2.46M799.006.96M8.37M8.89M17.58M18.44M18.44M16.71M16.59M16.39M3.08M5.94M
Other Operating Expenses 0.02M23.10M
Operating Expenses 11.87M0.02M12.56M16.61M28.59M39.87M59.93M73.44M63.24M83.25M69.38M11.87M14.10M
Operating Income 0.55M-0.02M-7.20M-13.68M-22.76M-14.59M-30.83M-27.16M-33.92M-51.83M-43.47M-11.87M-14.10M
EBIT 0.55M-0.02M-7.20M-13.68M-22.76M-14.59M-30.83M-27.16M-33.92M-51.83M-43.47M-11.87M-14.10M
Non-operating items
Interest & Investment Income -2.65M-0.18M0.00M0.15M1.96M1.71M0.51M0.00M0.72M1.85M
Other Non Operating Income 0.02M0.00M0.01M0.12M-2.10M1.80M-0.03M-3.66M2.40M1.30M0.71M1.10M
Non Operating Income -0.49M0.00M0.01M0.12M-2.10M1.80M-0.03M-3.66M2.40M1.30M0.71M0.51M
Net income details
EBT 0.07M-0.02M-9.85M-13.85M-22.64M-16.54M-27.07M-25.47M-37.07M-45.74M-42.75M18.69M-17.43M
Tax Provisions -18.000.20M0.16M1.10M-0.31M0.16M
Profit After Tax 0.07M-0.02M-9.85M-14.06M-22.80M-17.65M-26.75M-25.50M-37.23M-45.74M-33.30M18.69M-17.43M
Income from Continuing Operations 0.07M-0.02M-9.85M-14.06M-22.80M-17.65M-26.75M-25.47M-37.23M-45.74M-42.75M18.69M-17.43M
Consolidated Net Income 0.07M-0.02M-9.85M-14.06M-22.80M-17.65M-26.75M-25.47M-37.23M-45.74M-42.75M18.69M-17.43M
Income towards Parent Company 0.07M-0.02M-9.85M-14.06M-22.80M-17.65M-26.75M-25.47M-37.23M-45.74M-42.75M18.69M-17.43M
Preferred Dividend Payments 2.83M0.78M
Net Income towards Common Stockholders 0.07M-0.02M-9.85M-14.06M-22.80M-17.65M-26.75M-28.30M-37.23M-45.74M-42.75M17.91M-17.43M
Additional items
EPS (Basic) 0.01-0.71-0.41-0.55-0.40-0.50-0.56-0.68-0.71-0.452.19-7.83
EPS (Weighted Average and Diluted) -0.68-0.712.17-7.83
Shares Outstanding (Weighted Average) 0.37M0.50M0.54M0.56M0.68M0.69M0.70M0.90M0.93M1.24M1.32M
Shares Outstanding (Diluted Average) 54.48M64.55M
EBITDA 0.55M-0.02M-7.20M-13.68M-23.03M-20.84M-25.04M-24.48M-35.53M-44.61M-34.36M17.91M-17.43M
Interest Expenses 0.49M2.65M0.43M
Tax Rate 0.00%1.15%